What is the recommended protocol for using regional citrate anticoagulation in continuous renal replacement therapy (CRRT), including dosing, monitoring, and alternatives?

Regional Citrate Anticoagulation for CRRT

Regional citrate anticoagulation should be your first-line anticoagulation strategy for CRRT in patients without contraindications, as it reduces bleeding risk and prolongs filter life compared to heparin. 1

When to Use Citrate vs. Heparin

First-Line: Regional Citrate Anticoagulation

Use citrate as your default anticoagulation for CRRT in:

• Patients without increased bleeding risk who aren't on systemic anticoagulation 1
• Patients WITH increased bleeding risk - citrate is actually preferred over no anticoagulation in this group 1
• Patients requiring prolonged filter life and circuit patency 2, 3

Use Heparin Instead When:

Switch to unfractionated or low-molecular-weight heparin when citrate is contraindicated 1:

• Severe liver failure (though this is relative - see caveats below)
• Shock with severe muscle hypoperfusion (though this is also debated)

Special Situation - HIT:

If heparin-induced thrombocytopenia develops, immediately stop all heparin and use direct thrombin inhibitors (argatroban) or Factor Xa inhibitors instead 1

Practical Protocol Implementation

Initial Citrate Dosing

Start with 2.5-3.0 mmol/L of blood flow 3, 4:

• Lower doses (2.5 mmol/L) reduce citrate-related complications without losing efficacy 3
• Adjust based on body weight: match dialysate flow to approximately 2 L/hr for average body size 4
• Target post-filter ionized calcium of 0.26-0.40 mmol/L 3

Calcium Replacement

• Infuse calcium post-dialyzer continuously
• Target systemic ionized calcium of 1.01-1.20 mmol/L 3
• Personalize initial calcium infusion rate based on patient's albumin level and filter effluent flow 5

Critical Monitoring Parameters

Monitor these parameters frequently 6, 7:

• Post-filter ionized calcium (every 4-6 hours initially)
• Systemic ionized calcium (every 4-6 hours initially)
• Total calcium to ionized calcium ratio - if >2.5, suspect citrate accumulation 5
• Acid-base status (pH, bicarbonate)
• Serum sodium (watch for hypernatremia)
• Lactate levels (elevated lactate increases citrate accumulation risk) 2

Signs of Citrate Accumulation

Watch for 2, 5:

• Total calcium >3 mmol/L
• Total Ca/ionized Ca ratio >2.5
• Increasing calcium supplementation requirements
• Widening anion gap
• Metabolic acidosis despite therapy

If citrate accumulation occurs: Reduce citrate flow rate or blood flow rate; increase dialysate flow 4

Important Caveats and Pitfalls

The "Contraindications" Aren't Absolute

The traditional contraindications of severe liver failure and shock are not absolute 6:

• Even in severe liver failure, citrate can be tracked by monitoring ionized calcium and total Ca/ionized Ca ratio 6
• A specialized "Shock protocol" with higher fixed citrate infusion rates and personalized calcium dosing can safely manage patients with presumed absent citrate metabolism 5
• In liver failure patients who are coagulopathic, heparin would be contraindicated anyway - citrate may be your only option 6

Protocol Requirements

Before implementing citrate anticoagulation 6:

• Establish a strict written protocol detailing citrate infusion rates, calcium replacement, dialysate composition, and monitoring frequency
• Ensure adequate staff education to avoid metabolic complications
• Have specialized laboratory monitoring readily available (not just bedside testing)

Cost Considerations

Citrate is more expensive than heparin due to 6:

• Cost of citrate solutions
• More intensive metabolic monitoring required
• However, prolonged filter life may offset these costs

Metabolic Complications to Manage

Common issues include 2, 3, 8:

• Hypocalcemia (most common in first 4-6 hours) - usually corrects with protocol-driven calcium infusion
• Metabolic alkalosis (less common with lower citrate doses)
• Hypernatremia (rare with proper protocols)
• Hypomagnesemia (may require supplementation) 8

High-Risk Populations for Citrate Accumulation

Be extra vigilant in 2:

• Chronic liver disease patients
• Post-liver transplant recipients
• Patients with baseline lactate >6 mmol/L
• Patients with shock requiring high vasopressor doses

Expected Outcomes

With proper citrate protocols, you should achieve 2, 3, 4:

• Median filter life: 50-72 hours (vs. 24-48 hours with heparin)
• Circuit clotting rate: <10%
• Citrate accumulation: <5-10% (manageable with protocol adjustments)
• Bleeding complications: significantly reduced compared to heparin

The evidence strongly supports citrate as superior to heparin for reducing morbidity (bleeding, transfusions) while maintaining circuit patency, making it the clear first choice when feasible.